Annual Current Liabilities
$294.90 K
-$1.22 M-80.48%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual total current liabilities is $294.90 thousand, with the most recent change of -$1.22 million (-80.48%) on December 1, 2023.
- During the last 3 years, XRTX annual current liabilities has fallen by -$516.10 thousand (-63.64%).
- XRTX annual current liabilities is now -80.48% below its all-time high of $1.51 million, reached on December 31, 2022.
Performance
XRTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.72 M
+$1.20 M+229.14%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly total current liabilities is $1.72 million, with the most recent change of +$1.20 million (+229.14%) on September 1, 2024.
- Over the past year, XRTX quarterly current liabilities has increased by +$1.42 million (+482.16%).
- XRTX quarterly current liabilities is now -81.86% below its all-time high of $9.46 million, reached on September 1, 2021.
Performance
XRTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
XRTX Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -80.5% | +482.2% |
3 y3 years | -63.6% | +186.2% |
5 y5 years | -55.4% | +186.2% |
XRTX Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -80.5% | at low | at high | +482.2% |
5 y | 5-year | -80.5% | at low | -81.9% | +482.2% |
alltime | all time | -80.5% | +4656.4% | -81.9% | >+9999.0% |
XORTX Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.72 M(+229.1%) |
Jun 2024 | - | $521.60 K(+53.0%) |
Mar 2024 | - | $340.90 K(+15.6%) |
Dec 2023 | $294.90 K(-80.5%) | $294.90 K(-46.7%) |
Sep 2023 | - | $553.80 K(+37.3%) |
Jun 2023 | - | $403.30 K(-32.8%) |
Mar 2023 | - | $599.80 K(-60.3%) |
Dec 2022 | $1.51 M(+174.8%) | $1.51 M(+6.3%) |
Sep 2022 | - | $1.42 M(+84.1%) |
Jun 2022 | - | $772.10 K(+12.6%) |
Mar 2022 | - | $685.50 K(+24.0%) |
Dec 2021 | $549.80 K(-32.2%) | - |
Dec 2021 | - | $552.90 K(-94.2%) |
Sep 2021 | - | $9.46 M(+192.4%) |
Jun 2021 | - | $3.24 M(-14.5%) |
Mar 2021 | - | $3.78 M(+366.6%) |
Dec 2020 | $811.00 K(-18.5%) | $811.00 K(+9.2%) |
Sep 2020 | - | $743.00 K(+16.5%) |
Jun 2020 | - | $637.60 K(-22.7%) |
Mar 2020 | - | $825.00 K(-17.1%) |
Dec 2019 | $995.00 K | $995.00 K(+16.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $852.10 K(+9.8%) |
Jun 2019 | - | $776.40 K(+12.6%) |
Mar 2019 | - | $689.60 K(+4.3%) |
Dec 2018 | $661.10 K(-25.1%) | $661.10 K(-4.7%) |
Sep 2018 | - | $694.00 K(+10.1%) |
Jun 2018 | - | $630.10 K(-1.0%) |
Mar 2018 | - | $636.40 K(-27.9%) |
Dec 2017 | $882.30 K(+8466.0%) | $882.30 K(>+9900.0%) |
Nov 2017 | - | $6200.00(-99.1%) |
Sep 2017 | - | $688.90 K(>+9900.0%) |
Aug 2017 | - | $5600.00(-16.4%) |
May 2017 | - | $6700.00(-35.0%) |
Feb 2017 | $10.30 K(-97.7%) | $10.30 K(+49.3%) |
Dec 2016 | $446.00 K(+7093.5%) | - |
Nov 2016 | - | $6900.00(-86.5%) |
Aug 2016 | - | $51.30 K(+216.7%) |
May 2016 | - | $16.20 K(+161.3%) |
Feb 2016 | $6200.00(-87.1%) | $6200.00(-1.6%) |
Nov 2015 | - | $6300.00(-93.7%) |
Aug 2015 | - | $99.90 K(+43.9%) |
May 2015 | - | $69.40 K(+44.3%) |
Feb 2015 | $48.10 K | $48.10 K |
FAQ
- What is XORTX Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for XORTX Therapeutics?
- What is XORTX Therapeutics annual current liabilities year-on-year change?
- What is XORTX Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly current liabilities year-on-year change?
What is XORTX Therapeutics annual total current liabilities?
The current annual current liabilities of XRTX is $294.90 K
What is the all time high annual current liabilities for XORTX Therapeutics?
XORTX Therapeutics all-time high annual total current liabilities is $1.51 M
What is XORTX Therapeutics annual current liabilities year-on-year change?
Over the past year, XRTX annual total current liabilities has changed by -$1.22 M (-80.48%)
What is XORTX Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of XRTX is $1.72 M
What is the all time high quarterly current liabilities for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly total current liabilities is $9.46 M
What is XORTX Therapeutics quarterly current liabilities year-on-year change?
Over the past year, XRTX quarterly total current liabilities has changed by +$1.42 M (+482.16%)